Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
New study finds cell donor’s socioeconomic status shapes cancer treatment outcomes
Published in PNAS, a research team led by the University of Minnesota Medical School, USA, demonstrated…
Women with severe endometriosis are 10 times more likely to get ovarian cancer
A landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the…
Hormone therapy for breast cancer linked with lower dementia risk
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a…
Epilepsy drug could keep chemotherapy for stomach cancer working for longer
- RNAs may help identify stage II colon cancer patients who may benefit from chemotherapy following surgery
- One bad apple spoils the barrel: New study uncovers multiple molecular subgroups in liver cancer with most aggressive driving clinical outcomes
- US researchers awarded $2.78M federal grant to improve rectal cancer treatment with artificial intelligence
Fear of cancer returning is not only stressful for patients, it also costs the health care system money
Exclusive Commentary for OncologyNews by Alison Pearce, Ben Smith and Jake Williams Cancer survivors who worry a lot about their…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.